Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute
This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of ot...
Gespeichert in:
| Veröffentlicht in: | Clinical microbiology and infection 2003-10, Vol.9 (10), p.1068-1072 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1072 |
|---|---|
| container_issue | 10 |
| container_start_page | 1068 |
| container_title | Clinical microbiology and infection |
| container_volume | 9 |
| creator | Fanourgiakis, P. Georgala, A. Vekemans, M. Daneau, D. Heymans, C. Aoun, M. |
| description | This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of other pathogens causing bacteremia during neutropenia for the same period. S. mucilaginosus represented 5.9% of bacteremias in our neutropenic patients. Seven patients with hematologic malignancies and one with breast cancer are described. The common clinical presentation was one of sepsis. All patients presented with damaged mucosal barriers as the probable portal of entry, from either stomatitis or enterocolitis. All patients survived. |
| doi_str_mv | 10.1046/j.1469-0691.2003.00772.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71369794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1198743X14630718</els_id><sourcerecordid>19217954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5322-de8db20e14ecb0f99d2b288002935cccc85a64f556bb70823f2d4b9d7674c68e3</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhSNERUvhLyBvYJfgV-xYYkNHvKSpugAkdpZj3xSPkniwndL-e5zOiC5bb_y437Gvz6kqRHBDMBfvdw3hQtVYKNJQjFmDsZS0uX1Wnf0vPC9rorpacvbrtHqZ0g5jTBnjL6rTAhEhW3FW7S6MzRBh8ga5BVAO6HsOk8nBBmuXhKbF-tFc-zmksvMzmmHJMexh9hbtTfYw5_vz_BtQgpz9fI3CgAyyZrYQSylln5cMr6qTwYwJXh_n8-rn508_Nl_r7dWXb5uP29q2jNLaQed6ioFwsD0elHK0p11XelestWV0rRF8aFvR9xJ3lA3U8V45KSS3ogN2Xr073LuP4c8CKevJJwvjaGYIS9KSMKGk4o-CRFEiVbuC3QG0MaQUYdD76CcT7zTBeg1E7_Tqu15912sg-j4QfVukb45vLP0E7kF4TKAAb4-ASdaMQyyu-fTAtZRQ3naF-3Dg_voR7p7cgN5sL8uiyC8OcijO33iIOtkSnQXnI9isXfCPf-YflI69Jw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19217954</pqid></control><display><type>article</type><title>Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fanourgiakis, P. ; Georgala, A. ; Vekemans, M. ; Daneau, D. ; Heymans, C. ; Aoun, M.</creator><creatorcontrib>Fanourgiakis, P. ; Georgala, A. ; Vekemans, M. ; Daneau, D. ; Heymans, C. ; Aoun, M.</creatorcontrib><description>This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of other pathogens causing bacteremia during neutropenia for the same period. S. mucilaginosus represented 5.9% of bacteremias in our neutropenic patients. Seven patients with hematologic malignancies and one with breast cancer are described. The common clinical presentation was one of sepsis. All patients presented with damaged mucosal barriers as the probable portal of entry, from either stomatitis or enterocolitis. All patients survived.</description><identifier>ISSN: 1198-743X</identifier><identifier>EISSN: 1469-0691</identifier><identifier>DOI: 10.1046/j.1469-0691.2003.00772.x</identifier><identifier>PMID: 14616756</identifier><language>eng</language><publisher>Oxford, UK: Elsevier Ltd</publisher><subject>Adult ; Anti-Infective Agents - therapeutic use ; Bacteremia - complications ; Bacteremia - microbiology ; Bacterial diseases ; Bacterial sepsis ; Biological and medical sciences ; co-infection ; Female ; fluoroquinolone resistance ; Gram-Positive Bacterial Infections - complications ; Gram-Positive Bacterial Infections - drug therapy ; Gram-Positive Bacterial Infections - microbiology ; Hematologic and hematopoietic diseases ; Human bacterial diseases ; Humans ; Infectious diseases ; Male ; Medical sciences ; Micrococcaceae - isolation & purification ; Middle Aged ; Neoplasms - complications ; Neutropenia ; Neutropenia - complications ; oral mucositis ; Other diseases. Hematologic involvement in other diseases ; primary bacteremia ; Retrospective Studies ; Stomatococcus mucilaginosus</subject><ispartof>Clinical microbiology and infection, 2003-10, Vol.9 (10), p.1068-1072</ispartof><rights>2003 European Society of Clinical Infectious Diseases</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5322-de8db20e14ecb0f99d2b288002935cccc85a64f556bb70823f2d4b9d7674c68e3</citedby><cites>FETCH-LOGICAL-c5322-de8db20e14ecb0f99d2b288002935cccc85a64f556bb70823f2d4b9d7674c68e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1469-0691.2003.00772.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1469-0691.2003.00772.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27907,27908,45557,45558</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15212458$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14616756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fanourgiakis, P.</creatorcontrib><creatorcontrib>Georgala, A.</creatorcontrib><creatorcontrib>Vekemans, M.</creatorcontrib><creatorcontrib>Daneau, D.</creatorcontrib><creatorcontrib>Heymans, C.</creatorcontrib><creatorcontrib>Aoun, M.</creatorcontrib><title>Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute</title><title>Clinical microbiology and infection</title><addtitle>Clin Microbiol Infect</addtitle><description>This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of other pathogens causing bacteremia during neutropenia for the same period. S. mucilaginosus represented 5.9% of bacteremias in our neutropenic patients. Seven patients with hematologic malignancies and one with breast cancer are described. The common clinical presentation was one of sepsis. All patients presented with damaged mucosal barriers as the probable portal of entry, from either stomatitis or enterocolitis. All patients survived.</description><subject>Adult</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Bacteremia - complications</subject><subject>Bacteremia - microbiology</subject><subject>Bacterial diseases</subject><subject>Bacterial sepsis</subject><subject>Biological and medical sciences</subject><subject>co-infection</subject><subject>Female</subject><subject>fluoroquinolone resistance</subject><subject>Gram-Positive Bacterial Infections - complications</subject><subject>Gram-Positive Bacterial Infections - drug therapy</subject><subject>Gram-Positive Bacterial Infections - microbiology</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Micrococcaceae - isolation & purification</subject><subject>Middle Aged</subject><subject>Neoplasms - complications</subject><subject>Neutropenia</subject><subject>Neutropenia - complications</subject><subject>oral mucositis</subject><subject>Other diseases. Hematologic involvement in other diseases</subject><subject>primary bacteremia</subject><subject>Retrospective Studies</subject><subject>Stomatococcus mucilaginosus</subject><issn>1198-743X</issn><issn>1469-0691</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtv1DAUhSNERUvhLyBvYJfgV-xYYkNHvKSpugAkdpZj3xSPkniwndL-e5zOiC5bb_y437Gvz6kqRHBDMBfvdw3hQtVYKNJQjFmDsZS0uX1Wnf0vPC9rorpacvbrtHqZ0g5jTBnjL6rTAhEhW3FW7S6MzRBh8ga5BVAO6HsOk8nBBmuXhKbF-tFc-zmksvMzmmHJMexh9hbtTfYw5_vz_BtQgpz9fI3CgAyyZrYQSylln5cMr6qTwYwJXh_n8-rn508_Nl_r7dWXb5uP29q2jNLaQed6ioFwsD0elHK0p11XelestWV0rRF8aFvR9xJ3lA3U8V45KSS3ogN2Xr073LuP4c8CKevJJwvjaGYIS9KSMKGk4o-CRFEiVbuC3QG0MaQUYdD76CcT7zTBeg1E7_Tqu15912sg-j4QfVukb45vLP0E7kF4TKAAb4-ASdaMQyyu-fTAtZRQ3naF-3Dg_voR7p7cgN5sL8uiyC8OcijO33iIOtkSnQXnI9isXfCPf-YflI69Jw</recordid><startdate>200310</startdate><enddate>200310</enddate><creator>Fanourgiakis, P.</creator><creator>Georgala, A.</creator><creator>Vekemans, M.</creator><creator>Daneau, D.</creator><creator>Heymans, C.</creator><creator>Aoun, M.</creator><general>Elsevier Ltd</general><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200310</creationdate><title>Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute</title><author>Fanourgiakis, P. ; Georgala, A. ; Vekemans, M. ; Daneau, D. ; Heymans, C. ; Aoun, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5322-de8db20e14ecb0f99d2b288002935cccc85a64f556bb70823f2d4b9d7674c68e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Bacteremia - complications</topic><topic>Bacteremia - microbiology</topic><topic>Bacterial diseases</topic><topic>Bacterial sepsis</topic><topic>Biological and medical sciences</topic><topic>co-infection</topic><topic>Female</topic><topic>fluoroquinolone resistance</topic><topic>Gram-Positive Bacterial Infections - complications</topic><topic>Gram-Positive Bacterial Infections - drug therapy</topic><topic>Gram-Positive Bacterial Infections - microbiology</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Micrococcaceae - isolation & purification</topic><topic>Middle Aged</topic><topic>Neoplasms - complications</topic><topic>Neutropenia</topic><topic>Neutropenia - complications</topic><topic>oral mucositis</topic><topic>Other diseases. Hematologic involvement in other diseases</topic><topic>primary bacteremia</topic><topic>Retrospective Studies</topic><topic>Stomatococcus mucilaginosus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fanourgiakis, P.</creatorcontrib><creatorcontrib>Georgala, A.</creatorcontrib><creatorcontrib>Vekemans, M.</creatorcontrib><creatorcontrib>Daneau, D.</creatorcontrib><creatorcontrib>Heymans, C.</creatorcontrib><creatorcontrib>Aoun, M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical microbiology and infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fanourgiakis, P.</au><au>Georgala, A.</au><au>Vekemans, M.</au><au>Daneau, D.</au><au>Heymans, C.</au><au>Aoun, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute</atitle><jtitle>Clinical microbiology and infection</jtitle><addtitle>Clin Microbiol Infect</addtitle><date>2003-10</date><risdate>2003</risdate><volume>9</volume><issue>10</issue><spage>1068</spage><epage>1072</epage><pages>1068-1072</pages><issn>1198-743X</issn><eissn>1469-0691</eissn><abstract>This study reviews the clinical manifestations, causes and frequency of Stomatococcus mucilaginosus bacteremia in neutropenic cancer patients. We analyzed retrospectively all clinical and microbiological records of patients with S. mucilaginosus bacteremia. The incidence was compared with that of other pathogens causing bacteremia during neutropenia for the same period. S. mucilaginosus represented 5.9% of bacteremias in our neutropenic patients. Seven patients with hematologic malignancies and one with breast cancer are described. The common clinical presentation was one of sepsis. All patients presented with damaged mucosal barriers as the probable portal of entry, from either stomatitis or enterocolitis. All patients survived.</abstract><cop>Oxford, UK</cop><pub>Elsevier Ltd</pub><pmid>14616756</pmid><doi>10.1046/j.1469-0691.2003.00772.x</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1198-743X |
| ispartof | Clinical microbiology and infection, 2003-10, Vol.9 (10), p.1068-1072 |
| issn | 1198-743X 1469-0691 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71369794 |
| source | Wiley Online Library - AutoHoldings Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adult Anti-Infective Agents - therapeutic use Bacteremia - complications Bacteremia - microbiology Bacterial diseases Bacterial sepsis Biological and medical sciences co-infection Female fluoroquinolone resistance Gram-Positive Bacterial Infections - complications Gram-Positive Bacterial Infections - drug therapy Gram-Positive Bacterial Infections - microbiology Hematologic and hematopoietic diseases Human bacterial diseases Humans Infectious diseases Male Medical sciences Micrococcaceae - isolation & purification Middle Aged Neoplasms - complications Neutropenia Neutropenia - complications oral mucositis Other diseases. Hematologic involvement in other diseases primary bacteremia Retrospective Studies Stomatococcus mucilaginosus |
| title | Bacteremia due to Stomatococcus mucilaginosus in neutropenic patients in the setting of a cancer institute |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T04%3A37%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacteremia%20due%20to%20Stomatococcus%20mucilaginosus%20in%20neutropenic%20patients%20in%20the%20setting%20of%20a%20cancer%20institute&rft.jtitle=Clinical%20microbiology%20and%20infection&rft.au=Fanourgiakis,%20P.&rft.date=2003-10&rft.volume=9&rft.issue=10&rft.spage=1068&rft.epage=1072&rft.pages=1068-1072&rft.issn=1198-743X&rft.eissn=1469-0691&rft_id=info:doi/10.1046/j.1469-0691.2003.00772.x&rft_dat=%3Cproquest_cross%3E19217954%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19217954&rft_id=info:pmid/14616756&rft_els_id=S1198743X14630718&rfr_iscdi=true |